250 Users Online
A Detailed Analysis of the Blood Screening Market Based on Is Experiencing Robust Growth Driven by Increasing Demand for Advanced Diagnostic Technologies, Rising Awareness of Infectious Diseases, and Continuous Advancements in Screening Techniques
1. Executive Summary
1.1. Global Blood Screening Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Technology Lifecycle Analysis
2.4. Global Blood Screening Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Blood Screening Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Blood Screening Market Outlook: Technology
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Technology, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
3.3.3.1. Nucleic Acid Amplification Test (NAT)
3.3.3.2. ELISA
3.3.3.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
3.3.3.4. Next Generation Sequencing
3.3.3.5. Western Blotting
3.4. Market Attractiveness Analysis: Technology
3.5. Global Blood Screening Market Outlook: Product
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
3.5.3.1. Nucleic Acid Amplification Test (NAT)
3.5.3.2. ELISA
3.5.3.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
3.5.3.4. Next Generation Sequencing
3.5.3.5. Western Blotting
3.6. Market Attractiveness Analysis: Product
4. Global Blood Screening Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Global Blood Screening Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Technology
5.3.3. By Product
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
5.5.1. Nucleic Acid Amplification Test (NAT)
5.5.2. ELISA
5.5.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
5.5.4. Next Generation Sequencing
5.5.5. Western Blotting
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
5.6.1. Nucleic Acid Amplification Test (NAT)
5.6.2. ELISA
5.6.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
5.6.4. Next Generation Sequencing
5.6.5. Western Blotting
5.7. Market Attractiveness Analysis
6. Europe Global Blood Screening Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Technology
6.3.3. By Product
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
6.5.1. Nucleic Acid Amplification Test (NAT)
6.5.2. ELISA
6.5.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
6.5.4. Next Generation Sequencing
6.5.5. Western Blotting
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
6.6.1. Nucleic Acid Amplification Test (NAT)
6.6.2. ELISA
6.6.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
6.6.4. Next Generation Sequencing
6.6.5. Western Blotting
6.7. Market Attractiveness Analysis
7. East Asia Global Blood Screening Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Technology
7.3.3. By Product
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
7.5.1. Nucleic Acid Amplification Test (NAT)
7.5.2. ELISA
7.5.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
7.5.4. Next Generation Sequencing
7.5.5. Western Blotting
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
7.6.1. Nucleic Acid Amplification Test (NAT)
7.6.2. ELISA
7.6.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
7.6.4. Next Generation Sequencing
7.6.5. Western Blotting
7.7. Market Attractiveness Analysis
8. South Asia & Oceania Global Blood Screening Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Technology
8.3.3. By Product
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
8.5.1. Nucleic Acid Amplification Test (NAT)
8.5.2. ELISA
8.5.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
8.5.4. Next Generation Sequencing
8.5.5. Western Blotting
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
8.6.1. Nucleic Acid Amplification Test (NAT)
8.6.2. ELISA
8.6.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
8.6.4. Next Generation Sequencing
8.6.5. Western Blotting
8.7. Market Attractiveness Analysis
9. Latin America Global Blood Screening Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Technology
9.3.3. By Product
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
9.5.1. Nucleic Acid Amplification Test (NAT)
9.5.2. ELISA
9.5.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
9.5.4. Next Generation Sequencing
9.5.5. Western Blotting
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
9.6.1. Nucleic Acid Amplification Test (NAT)
9.6.2. ELISA
9.6.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
9.6.4. Next Generation Sequencing
9.6.5. Western Blotting
9.7. Market Attractiveness Analysis
10. Middle East & Africa Global Blood Screening Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Technology
10.3.3. By Product
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
10.5.1. Nucleic Acid Amplification Test (NAT)
10.5.2. ELISA
10.5.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
10.5.4. Next Generation Sequencing
10.5.5. Western Blotting
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
10.6.1. Nucleic Acid Amplification Test (NAT)
10.6.2. ELISA
10.6.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
10.6.4. Next Generation Sequencing
10.6.5. Western Blotting
10.7. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Analog IC
11.2.3. Apparent Technology Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Abbott
11.3.1.1. Overview
11.3.1.2. Segments and Technology
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Becton Dickinson and Company
11.3.2.1. Overview
11.3.2.2. Segments and Technology
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Bio-Rad Laboratories, Inc.
11.3.3.1. Overview
11.3.3.2. Segments and Technology
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Hoffman-La Roche Ltd.
11.3.4.1. Overview
11.3.4.2. Segments and Technology
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Grifols, S.A.
11.3.5.1. Overview
11.3.5.2. Segments and Technology
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Ortho-Clinical Diagnostics, Inc.
11.3.6.1. Overview
11.3.6.2. Segments and Technology
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Siemens Healthcare GmbH
11.3.7.1. Overview
11.3.7.2. Segments and Technology
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Thermo Fisher Scientific, Inc.
11.3.8.1. Overview
11.3.8.2. Segments and Technology
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. SOFINA s.a (Biomerieux)
11.3.9.1. Overview
11.3.9.2. Segments and Technology
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Danaher Corporation (Beckman Coulter)
11.3.10.1. Overview
11.3.10.2. Segments and Technology
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
